SCH 66336 Plus Gemcitabine in Treating Patients With Advanced Cancer of the Urinary Tract

NCT00006351 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

34

Enrollment

NETWORK

Sponsor class

Conditions

Bladder Cancer
Transitional Cell Cancer of the Renal Pelvis and Ureter
Urethral Cancer

Interventions

DRUG: gemcitabine hydrochloride
DRUG: lonafarnib

Sponsor

European Organisation for Research and Treatment of Cancer - EORTC